The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

Also called NCT02411903

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
The Third Affiliated Hospital of Guangzhou Medical University (from the registry)
Registry
  • NCT NCT02411903
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02411903. Randomized; no masking; primary purpose treatment. Start 2015-03 (registry gives no type); primary completion 2016-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized and Cytochrome P450 Isoenzyme 3A4(CYP3A4)-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
Condition
Cerebral Infarction
Condition
Clopidogrel,Poor Metabolism of (Disorder)
Intervention (Drug)
atorvastatin and clopidogrel
Intervention (Drug)
rosuvastatin and clopidogrel
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University (class: other)

Record details

Record id
cardio:ct-nct02411903
Content hash
034df9996540859ed245551e900534de0efcf9732f5e172a8012905065a0932c